ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

SLN Silence Therapeutics PLC

21.90
-0.09 (-0.41%)
Fuera de horario
Última actualización: 15:02:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Silence Therapeutics PLC SLN NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.09 -0.41% 21.90 15:02:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
22.09 21.87 22.69 21.90 21.99
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202407:30BWSilence Therapeutics to Participate in Fireside Chat at H.C...
29/4/202407:30BWSilence Therapeutics Announces Retirement of Alistair Gray..
08/4/202410:48BWSilence Therapeutics Announces JAMA Publication of..
13/3/202406:05BWSilence Therapeutics Reports Full Year 2023 Financial..
13/3/202406:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
13/3/202406:00BWSilence Therapeutics Announces Positive Topline 36-Week Data..
28/2/202407:00BWSilence Therapeutics to Report Fourth Quarter and Full Year..
23/2/202407:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202407:00BWSilence Therapeutics Achieves $10 Million Milestone Payment..
14/2/202408:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202407:00BWSilence Therapeutics Announces Oversubscribed $120 Million..
31/1/202406:00BWSilence Therapeutics to Participate in Fireside Chat at..
01/12/202306:00BWSilence Therapeutics Strengthens Executive Leadership Team..
14/11/202306:00BWSilence Therapeutics Highlights Recent Company Progress and..
08/11/202306:00BWSilence Therapeutics to Present at Jefferies London..
01/11/202306:00BWSilence Therapeutics Announces Positive Topline Results from..
26/9/202306:00BWSilence Therapeutics to Participate in Fireside Chat at..
06/9/202306:00BWSilence Therapeutics to Participate in September Investor..
29/8/202315:01EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16/8/202306:00BWSilence Therapeutics Reports Second Quarter 2023 Results
01/8/202315:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/7/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202306:00BWSilence Therapeutics Achieves $4 Million in Research..
31/5/202306:00BWSilence Therapeutics to Present at the Jefferies Healthcare..
16/5/202315:00BWSilence Therapeutics Reports First Quarter 2023 Results

Su Consulta Reciente

Delayed Upgrade Clock